Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$70.46
0.851.22%
À la fermeture: -
$70.52
0.060.09%
Après les heures de négociation: 7:42 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Abercrombie & Fitch Co a un objectif de cours consensus de $116.77, basé sur les évaluations des 14 analystes. Le plus élevé est de $210 attribué par UBS le février 24, 2025, et le plus bas est de $41 attribué par Argus Research le juin 12, 2023. Les 3 dernières évaluations d'analystes ont été publiées par JP Morgan, BTIG et Telsey Advisory Group le octobre 6, 2025, septembre 18, 2025 et septembre 12, 2025. Avec un objectif de cours moyen de $116 entre JP Morgan, BTIG et Telsey Advisory Group, il y a une variation implicite de 64.49% upside pour Abercrombie & Fitch Co à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
JP Morgan
BTIG
Telsey Advisory Group
Citigroup
Raymond James
1calculé à partir des notes des analystes
Notes d'analystes pour Abercrombie & Fitch
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/06/2025 | 46.06% | JP Morgan | → $103 | Downgrade | Overweight → Neutral | |||
09/18/2025 | 70.16% | BTIG | → $120 | Initiates | → Buy | |||
09/12/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/28/2025 | 105.62% | JP Morgan | $151 → $145 | Maintains | Overweight | |||
08/28/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/27/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/20/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/20/2025 | 48.89% | Citigroup | → $105 | Downgrade | Buy → Neutral | |||
07/28/2025 | 114.12% | JP Morgan | $141 → $151 | Maintains | Overweight | |||
06/16/2025 | 99.94% | JP Morgan | $147 → $141 | Maintains | Overweight | |||
05/29/2025 | 40.39% | Raymond James | $90 → $99 | Maintains | Outperform | |||
05/29/2025 | 16.28% | Morgan Stanley | $78 → $82 | Maintains | Equal-Weight | |||
05/29/2025 | 19.12% | Barclays | $71 → $84 | Maintains | Equal-Weight | |||
05/29/2025 | 108.45% | JP Morgan | $142 → $147 | Maintains | Overweight | |||
05/29/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
05/28/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
05/27/2025 | 27.62% | Raymond James | $110 → $90 | Maintains | Outperform | |||
05/21/2025 | 91.44% | Jefferies | $170 → $135 | Maintains | Buy | |||
05/19/2025 | 101.36% | JP Morgan | $155 → $142 | Maintains | Overweight | |||
05/19/2025 | 84.34% | UBS | $115 → $130 | Maintains | Buy | |||
05/06/2025 | 10.61% | Morgan Stanley | $114 → $78 | Maintains | Equal-Weight | |||
04/21/2025 | 0.68% | Barclays | → $71 | Initiates | → Equal-Weight | |||
04/14/2025 | 119.8% | JP Morgan | $168 → $155 | Maintains | Overweight | |||
04/08/2025 | 38.97% | Citigroup | $135 → $98 | Maintains | Buy | |||
03/06/2025 | 55.98% | Raymond James | $124 → $110 | Maintains | Outperform | |||
03/06/2025 | 112.71% | UBS | $210 → $150 | Maintains | Buy | |||
03/06/2025 | 91.44% | Citigroup | $160 → $135 | Maintains | Buy | |||
03/06/2025 | 77.25% | Telsey Advisory Group | $190 → $125 | Maintains | Outperform | |||
03/05/2025 | 138.23% | JP Morgan | $189 → $168 | Maintains | Overweight | |||
03/05/2025 | 141.07% | Jefferies | $220 → $170 | Maintains | Buy | |||
02/26/2025 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
02/24/2025 | 197.79% | UBS | $220 → $210 | Maintains | Buy | |||
01/15/2025 | 97.11% | Morgan Stanley | $149 → $139 | Maintains | Equal-Weight | |||
01/14/2025 | 133.98% | Raymond James | $180 → $165 | Maintains | Outperform | |||
01/14/2025 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
01/10/2025 | 211.97% | UBS | $173 → $220 | Upgrade | Neutral → Buy | |||
12/20/2024 | 189.28% | JP Morgan | $201 → $204 | Maintains | Overweight | |||
12/06/2024 | 155.25% | Raymond James | → $180 | Initiates | → Outperform | |||
11/27/2024 | 145.32% | UBS | $170 → $173 | Maintains | Neutral | |||
11/27/2024 | 111.29% | Morgan Stanley | $147 → $149 | Maintains | Equal-Weight | |||
11/26/2024 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
11/14/2024 | 141.07% | UBS | $165 → $170 | Maintains | Neutral | |||
10/04/2024 | 176.52% | JP Morgan | $194 → $195 | Maintains | Overweight | |||
09/11/2024 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
09/04/2024 | 211.97% | Jefferies | $215 → $220 | Maintains | Buy | |||
08/30/2024 | 169.43% | Citigroup | → $190 | Upgrade | Neutral → Buy | |||
08/29/2024 | 108.45% | Morgan Stanley | $155 → $147 | Maintains | Equal-Weight | |||
08/29/2024 | 133.98% | UBS | $193 → $165 | Maintains | Neutral | |||
08/28/2024 | 194.95% | Telsey Advisory Group | $208 → $208 | Maintains | Outperform | |||
08/21/2024 | 194.95% | Telsey Advisory Group | $208 → $208 | Maintains | Outperform | |||
07/22/2024 | 175.1% | JP Morgan | $167 → $194 | Upgrade | Neutral → Overweight | |||
07/11/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
05/30/2024 | 169.43% | Citigroup | $150 → $190 | Maintains | Neutral | |||
05/30/2024 | 173.68% | UBS | $155 → $193 | Maintains | Neutral | |||
05/30/2024 | 143.9% | Morgan Stanley | $112 → $172 | Maintains | Equal-Weight | |||
05/30/2024 | 194.95% | Telsey Advisory Group | $152 → $208 | Maintains | Outperform | |||
05/29/2024 | 136.81% | JP Morgan | $144 → $167 | Maintains | Neutral | |||
05/29/2024 | 204.88% | Jefferies | $155 → $215 | Maintains | Buy | |||
05/29/2024 | 115.54% | Telsey Advisory Group | $152 → $152 | Maintains | Outperform | |||
05/23/2024 | 115.54% | Telsey Advisory Group | $152 → $152 | Maintains | Outperform | |||
05/21/2024 | 112.71% | Citigroup | $140 → $150 | Maintains | Neutral | |||
05/21/2024 | 119.8% | UBS | $145 → $155 | Maintains | Neutral | |||
05/17/2024 | 104.2% | JP Morgan | $125 → $144 | Maintains | Neutral | |||
05/06/2024 | 58.82% | Morgan Stanley | $103 → $112 | Maintains | Equal-Weight | |||
04/11/2024 | 84.34% | Argus Research | $97 → $130 | Maintains | Buy | |||
03/07/2024 | 98.53% | Citigroup | $127 → $140 | Maintains | Neutral | |||
03/07/2024 | 46.06% | Morgan Stanley | $81 → $103 | Maintains | Equal-Weight | |||
03/07/2024 | 115.54% | Telsey Advisory Group | $140 → $152 | Maintains | Outperform | |||
03/06/2024 | 98.53% | Telsey Advisory Group | $140 → $140 | Reiterates | Outperform → Outperform | |||
03/06/2024 | 119.8% | Jefferies | $149 → $155 | Maintains | Buy | |||
02/28/2024 | 98.53% | Telsey Advisory Group | — | $105 → $140 | Maintains | Outperform | ||
02/27/2024 | 80.09% | Citigroup | $100 → $127 | Maintains | Neutral | |||
02/26/2024 | 84.34% | UBS | $98 → $130 | Maintains | Neutral | |||
01/09/2024 | 41.8% | Citigroup | $82 → $100 | Maintains | Neutral | |||
01/09/2024 | 48.89% | Telsey Advisory Group | $95 → $105 | Maintains | Outperform | |||
01/09/2024 | 38.97% | UBS | $93 → $98 | Maintains | Neutral | |||
11/22/2023 | 16.28% | Citigroup | $75 → $82 | Maintains | Neutral | |||
11/22/2023 | 6.35% | UBS | $70 → $75 | Maintains | Neutral | |||
11/22/2023 | -3.57% | Morgan Stanley | $53 → $68 | Maintains | Equal-Weight | |||
11/22/2023 | 17.7% | Telsey Advisory Group | $74 → $83 | Maintains | Outperform | |||
11/21/2023 | 4.93% | Telsey Advisory Group | $74 → $74 | Reiterates | Outperform → Outperform | |||
11/14/2023 | 4.93% | Telsey Advisory Group | $62 → $74 | Maintains | Outperform | |||
11/13/2023 | -0.74% | UBS | $53 → $70 | Maintains | Neutral | |||
09/07/2023 | -12.08% | Telsey Advisory Group | $56 → $62 | Maintains | Outperform | |||
08/25/2023 | -27.68% | Morgan Stanley | $18 → $51 | Upgrade | Underweight → Equal-Weight | |||
08/24/2023 | -12.08% | JP Morgan | $45 → $62 | Maintains | Neutral | |||
08/24/2023 | -24.84% | UBS | $42 → $53 | Maintains | Neutral | |||
08/24/2023 | -20.59% | Telsey Advisory Group | $47 → $56 | Maintains | Outperform | |||
08/23/2023 | -33.35% | Telsey Advisory Group | $47 → $47 | Reiterates | Outperform → Outperform | |||
08/16/2023 | -33.35% | Telsey Advisory Group | $35 → $47 | Maintains | Outperform | |||
08/15/2023 | -36.19% | Citigroup | $33 → $45 | Maintains | Neutral | |||
06/12/2023 | -41.86% | Argus Research | → $41 | Upgrade | Hold → Buy | |||
05/25/2023 | -74.48% | Morgan Stanley | $17 → $18 | Maintains | Underweight | |||
05/25/2023 | -53.2% | Citigroup | $24 → $33 | Maintains | Neutral | |||
05/25/2023 | -54.62% | UBS | $28 → $32 | Maintains | Neutral | |||
05/25/2023 | -50.37% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform | |||
05/24/2023 | -50.37% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform | |||
05/18/2023 | -65.97% | Citigroup | $32 → $24 | Maintains | Neutral | |||
05/17/2023 | -50.37% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform | |||
05/09/2023 | -57.46% | Jefferies | $35 → $30 | Maintains | Buy |
FAQ
Quel est le cours indicatif de l'action Abercrombie & Fitch (ANF) ?
Le dernier objectif de prix pour Abercrombie & Fitch (NYSE:ANF) a été rapporté par JP Morgan le octobre 6, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $103.00 s'attendant à ce que ANF se rise dans les 12 prochains mois (un possible changement de 46.06% upside). 42 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Abercrombie & Fitch (ANF) ?
La dernière note d'analyste pour Abercrombie & Fitch (NYSE:ANF) a été fournie par JP Morgan, et Abercrombie & Fitch réduit leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Abercrombie & Fitch (ANF) ?
La dernière amélioration pour Abercrombie & Fitch Co a eu lieu le janvier 10, 2025 lorsque UBS a augmenté leur objectif de prix à $220. UBS avait précédemment a neutral pour Abercrombie & Fitch Co.
Quand a eu lieu la dernière dégradation pour Abercrombie & Fitch (ANF) ?
La dernière réduction pour Abercrombie & Fitch Co a eu lieu le octobre 6, 2025 lorsque JP Morgan a changé leur objectif de prix de N/A à $103 pour Abercrombie & Fitch Co.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Abercrombie & Fitch (ANF) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Abercrombie & Fitch, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Abercrombie & Fitch a été déposée le octobre 6, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 6, 2026.
La note d'analyste pour Abercrombie & Fitch (ANF) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Abercrombie & Fitch (ANF) était un réduit avec un objectif de prix de $0.00 à $103.00. Le prix actuel de Abercrombie & Fitch (ANF) est de $70.52, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.